Victoria M. Garbitt - Concepedia

Author

Victoria M. Garbitt

Mayo Clinic in Arizona ORCID

Also Known As

V M Garbitt, Victoria Garbitt, Victoria M Garbitt, Victoria M. Garbitt, Victoria Marie Garbitt

Publications

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic in Arizona Mayo Clinic Jacksonville College Translational Genomics Research Institute Mayo Clinic in Florida

About

Victoria M. Garbitt is an author at Mayo Clinic in Arizona specializing in tumor biology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	745
2	Cell Biology	3	3	576
3	Immunology	2	2	429
4	Cancer Cell Biology	1	1	155
5	Cancer Genetics	1	1	155

Victoria M. Garbitt

Publications

Citations

H-Index

Page 1

	Year	Citations
Clonal competition with alternating dominance in multiple myeloma Jonathan J. Keats, Marta Chesi, Jan B. Egan, Blood	2012	630
Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma Maurizio Affer, Marta Chesi, W D Chen, Leukemia Hematological MalignancyImmunologyHematologyMyelopoiesisMyc Expression	2014	260
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression Arianna Calcinotto, Arianna Brevi, Marta Chesi, Nature Communications	2018	210
Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy Marta Chesi, Geoffrey M. Matthews, Victoria M. Garbitt, Blood	2012	207
IAP antagonists induce anti-tumor immunity in multiple myeloma Marta Chesi, Noweeda Mirza, Victoria M. Garbitt, Nature Medicine Cancer ImmunosurveillanceImmunologyTumor ImmunityImmune Checkpoint InhibitorMultiple Myeloma	2016	169
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276 Jessica Schmidt, Esteban Braggio, K. Martin Kortuem, Leukemia Hematological MalignancyGenome-wide StudiesOncologyMedicineCancer Genomics	2013	161
SIK1 Couples LKB1 to p53-Dependent Anoikis and Suppresses Metastasis Hailing Cheng, Pixu Liu, Zhigang C. Wang, Science Signaling P53 FunctionMedicineReceptor Tyrosine KinaseSik1 Couples Lkb1Cancer Growth	2009	155
Tumor Burden Limits Bispecific Antibody Efficacy through T-cell Exhaustion Averted by Concurrent Cytotoxic Therapy Erin W. Meermeier, Seth J. Welsh, Meaghen E. Sharik, Blood Cancer Discovery	2021	96
Monosomic Loss of MIR15A/MIR16-1 Is a Driver of Multiple Myeloma Proliferation and Disease Progression Marta Chesi, Caleb K. Stein, Victoria M. Garbitt, Blood Cancer Discovery	2020	38
Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma Seth J. Welsh, Benjamin G. Barwick, Erin W. Meermeier, Blood Cancer Discovery	2023	33

Page 1